Cargando…

Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs

Detalles Bibliográficos
Autores principales: Faulkner, Lee, Wood, Sally, Van Eker, Diane, Alfirevic, Ana, Pirmohamed, Munir, Naisbitt, Dean, Park, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127670/
http://dx.doi.org/10.1186/2045-7022-4-S3-P112
_version_ 1782330051699671040
author Faulkner, Lee
Wood, Sally
Van Eker, Diane
Alfirevic, Ana
Pirmohamed, Munir
Naisbitt, Dean
Park, Kevin
author_facet Faulkner, Lee
Wood, Sally
Van Eker, Diane
Alfirevic, Ana
Pirmohamed, Munir
Naisbitt, Dean
Park, Kevin
author_sort Faulkner, Lee
collection PubMed
description
format Online
Article
Text
id pubmed-4127670
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41276702014-08-14 Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs Faulkner, Lee Wood, Sally Van Eker, Diane Alfirevic, Ana Pirmohamed, Munir Naisbitt, Dean Park, Kevin Clin Transl Allergy Poster Presentation BioMed Central 2014-07-18 /pmc/articles/PMC4127670/ http://dx.doi.org/10.1186/2045-7022-4-S3-P112 Text en Copyright © 2014 Faulkner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Faulkner, Lee
Wood, Sally
Van Eker, Diane
Alfirevic, Ana
Pirmohamed, Munir
Naisbitt, Dean
Park, Kevin
Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
title Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
title_full Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
title_fullStr Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
title_full_unstemmed Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
title_short Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
title_sort establishment of an hla-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive t cells to structurally divergent drugs
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127670/
http://dx.doi.org/10.1186/2045-7022-4-S3-P112
work_keys_str_mv AT faulknerlee establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs
AT woodsally establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs
AT vanekerdiane establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs
AT alfirevicana establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs
AT pirmohamedmunir establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs
AT naisbittdean establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs
AT parkkevin establishmentofanhlatypedcohortof1000healthyblooddonorsanduseofadendriticcellprimingassaytoprimenaivetcellstostructurallydivergentdrugs